RBC Capital maintains Palantir stock rating on valuation concerns By Investing.com

RBC Capital reiterated an Underperform on Palantir with a $90 price target ahead of Q1 2026 earnings, citing a 224.79 P/E valuation, declining quarterly contract value and net new annual contract value for a second straight quarter, and concerns that commercial momentum may be fading. The note contrasts with otherwise upbeat expectations for May 4 earnings and a newly announced $300 million USDA blanket purchase agreement. Overall, the article is mixed but skews negative due to valuation and demand concerns.

Analysis

The key risk here is not the headline valuation multiple by itself; it is the possibility that PLTR is entering the classic “good company, bad stock” phase where incremental upside in fundamentals gets progressively less levered to the equity because expectations are already extreme. If government contract value is rolling over while the commercial pipeline shows even mild churn, the market can re-rate the name sharply lower on any deceleration, since the current setup leaves little room for an “in-line but not sensational” quarter. That makes the next 1-2 earnings prints more important than the next 12 months of product narrative.

Second-order, the share price is likely constraining customer adoption at the margin. For some enterprise buyers, a platform that is perceived as expensive, politically sensitive, or hard to unwind becomes harder to justify versus modular AI/data alternatives from hyperscalers and incumbent software vendors. That creates a subtle feedback loop: if clients are already testing alternatives, each weak renewal or migration story increases the credibility of competitors and raises the sales cost of defending accounts.

The contrarian case is that the market may be over-discounting near-term churn while underestimating operating leverage if AI-related demand re-accelerates. A single large government award can mask a broader softness trend for a quarter or two, and if commercial expansion remains intact, the stock can keep levitating on narrative alone. But from a trading standpoint, that asymmetry cuts both ways: because the valuation is so stretched, the downside is more immediate and measurable than the upside unless the company beats and raises with clear evidence of durable demand inflection.

Catalyst-wise, the next 2-6 weeks matter most: earnings, guidance, and any commentary on customer concentration, renewal rates, and seat expansion will determine whether this is a temporary air pocket or a regime change. If the print is merely strong rather than exceptional, the stock is vulnerable to multiple compression; if management can show accelerating commercial conversion and stable gov bookings, the short thesis gets delayed but not eliminated.

Key Decisions for Investors

• Short PLTR into earnings or via post-print strength if the stock rallies >5% pre-report; use a 2-8 week horizon. Risk/reward favors downside compression because the current setup prices perfection, while even a solid quarter could de-rate the multiple by 15-25%.
• Buy PLTR put spreads 1-3 months out, struck around 10-15% below spot. This captures an earnings-driven selloff without paying for unlimited downside exposure if the stock grinds sideways.
• Pair trade: long a diversified AI infra beneficiary basket versus short PLTR for 1-2 quarters. The trade expresses skepticism on valuation concentration risk while keeping some participation in the AI theme if the sector remains bid.
• Reduce or hedge any existing PLTR long only on strength after earnings, not before. If guidance is merely steady, treat the reaction as an opportunity to trim because the market likely rewards only true upside surprise from here.
• For higher-conviction bearish exposure, structure a ratio put spread rather than outright shorting. That preserves convexity if the post-earnings move is outsized, while limiting borrow/mark risk in a name that can stay irrational for long periods.